Hypothesis

It's proposed that persistent stress granules in aged neurons serve as nucleation platforms that convert soluble misfolded proteins into amyloid‑like aggregates, thereby sequestering toxic species and temporarily shielding synaptic function. When clearance pathways decline, these granules persist and the aggregates shift from a benign, ordered state to a pathogenic load that impairs plasticity.

Mechanistic Basis

Stress granules concentrate RNA‑binding proteins (RBPs) such as TIA‑1 and G3BP1, which undergo liquid‑liquid phase separation and expose low‑complexity domains that can seed β‑sheet formation. In young cells, transient granules disassemble via VCP/p97‑dependent extraction, releasing RBPs and preventing irreversible aggregation. Aging reduces VCP activity and increases phosphorylation of RBPs (e.g., via CK2), stabilizing the granule core and promoting amyloid conversion of trapped substrates like synaptic proteins (PSD‑95, Synapsin‑1). The resulting aggregates are highly ordered, thermodynamically stable, and less prone to engage membranes, explaining the initial protective role observed in stress‑granule‑mediated translation inhibition.

When VCP‑mediated clearance falls below a threshold, granules become stable scaffolds. The seeded amyloid incorporates additional misfolded proteins, grows, and eventually interferes with microtubule transport and synaptic vesicle cycling. This shift aligns with data showing doubled neuronal protein half‑lives and enrichment of synaptic proteins in insoluble fractions in aged mice.

Novel Insight

The hypothesis reframes amyloid formation not as a random mistake but as a regulated phase‑transition driven by stress‑granule composition and VCP activity. It predicts that modulating granule dynamics—either enhancing disassembly or blocking nucleation—will alter aggregate toxicity without changing overall protein synthesis rates.

Testable Predictions

1. Pharmacological activation of VCP (e.g., with CB‑5083 analogs) in aged mouse basolateral amygdala will reduce persistent stress granules and lower insoluble amyloid‑like species without increasing soluble oligomers.
2. Knock‑down of TIA‑1 or expression of a low‑complexity domain mutant that cannot seed β‑sheets will prevent amyloid accumulation despite persistent granules, preserving fear‑extinction learning.
3. Artificially inducing stress‑granule formation via arsenite in young neurons will transiently increase ordered aggregates and improve resistance to oxidative stress, but chronic induction will replicate the aged phenotype.

Experimental Approach

• Use immunoblotting and filter‑trap assays to quantify soluble vs insoluble fractions of PSD‑95 and tau in amygdala lysates from young, aged, and VCP‑treated aged rats.
• Perform immunofluorescence colocalization of G3BP1, TIA‑1, and thioflavin‑S to map granule‑associated amyloid.
• Assess synaptic plasticity via field EPSPs in amygdala slices and fear‑extinction behavior after manipulations.
• Employ live‑cell FRAP on GFP‑TIA‑1 to measure granule dynamics under varying VCP activity.

If VCP enhancement reduces ordered aggregates and rescues behavior, the hypothesis gains support; if aggregates increase or toxicity worsens, the model is refuted. This framework links stress‑granule biology, proteostasis, and circuit‑specific vulnerability in brain aging.